Articles with public access mandates - Adekunle AdekileLearn more
Not available anywhere: 1
Anti-inflammatory cytokines in sickle cell disease
AE Alagbe, IF Domingos, AD Adekile, MHSL Blotta, MNN Santos
Molecular Biology Reports, 1-10, 2022
Mandates: Fundação de Amparo à Pesquisa do Estado de São Paulo
Available somewhere: 12
Current sickle cell disease management practices in Nigeria
N Galadanci, BJ Wudil, TM Balogun, GO Ogunrinde, A Akinsulie, ...
International health 6 (1), 23-28, 2014
Mandates: US National Institutes of Health
HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges
O Nnodu, H Isa, M Nwegbu, C Ohiaeri, S Adegoke, R Chianumba, ...
Blood Cells, Molecules, and Diseases 78, 22-28, 2019
Mandates: Wellcome Trust
Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study
OE Nnodu, A Sopekan, U Nnebe-Agumadu, C Ohiaeri, A Adeniran, ...
The Lancet Haematology 7 (7), e534-e540, 2020
Mandates: Wellcome Trust, Doris Duke Charitable Foundation
Global Genetic Architecture of an Erythroid Quantitative Trait Locus, HMIP‐2
S Menzel, H Rooks, D Zelenika, SN Mtatiro, A Gnanakulasekaran, ...
Annals of human genetics 78 (6), 434-451, 2014
Mandates: US National Institutes of Health, British Heart Foundation, UK Medical …
The Sickle Cell Disease Ontology: enabling universal sickle cell-based knowledge representation
Database 2019, baz118, 2019
Mandates: US National Institutes of Health, Wellcome Trust
Sickle cell disease clinical phenotypes in Nigeria: a preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database
H Isa, S Adegoke, A Madu, AA Hassan, C Ohiaeri, R Chianumba, ...
Blood Cells, Molecules, and Diseases 84, 102438, 2020
Mandates: US National Institutes of Health
Nitric oxide-cGMP signaling stimulates erythropoiesis through multiple lineage-specific transcription factors: clinical implications and a novel target for erythropoiesis
T Ikuta, H Sellak, N Odo, AD Adekile, KML Gaensler
PLoS One 11 (1), e0144561, 2016
Mandates: US National Institutes of Health
The proinflammatory cytokine GM-CSF downregulates fetal hemoglobin expression by attenuating the cAMP-dependent pathway in sickle cell disease
T Ikuta, AD Adekile, DR Gutsaeva, JB Parkerson, SD Yerigenahally, ...
Blood Cells, Molecules, and Diseases 47 (4), 235-242, 2011
Mandates: US National Institutes of Health
Hydroxyurea in children with sickle cell disease in a resource‐poor setting: Monitoring and effects of therapy. A practical perspective
U Nnebe‐Agumadu, I Adebayo, I Erigbuem, E James, E Kumode, ...
Pediatric Blood & Cancer 68 (6), e28969, 2021
Mandates: US National Institutes of Health
A multi-centre survey of acceptability of newborn screening for sickle cell disease in Nigeria
OE Nnodu, SA Adegoke, OU Ezenwosu, II Emodi, NI Ugwu, CN Ohiaeri, ...
Cureus 10 (3), 2018
Mandates: UK Medical Research Council
Proceedings of a Sickle Cell Disease Ontology workshop—Towards the first comprehensive ontology for sickle cell disease
N Mulder, V Nembaware, A Adekile, KA Anie, B Inusa, B Brown, ...
Applied & translational genomics 9, 23-29, 2016
Mandates: US National Institutes of Health
Utilization of pneumococcal vaccine and penicillin prophylaxis in sickle cell disease in three African countries: assessment among healthcare providers in SickleInAfrica
BJ Brown, A Madu, RZ Sangeda, S Nkya, E Peprah, V Paintsil, ...
Hemoglobin 45 (3), 163-170, 2021
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program